accessibility menu, dialog, popup

UserName

Pyrrolidiner

Organiske heterocykliske forbindelser, der består af en femleddet ring med fire carbonatomer og et nitrogenatom, der danner en cyklisk sekundær amin.

Filtrerede søgeresultater

Produkter fra nogle af vores leverandører vises ikke i filtrerede søgeresultater. ryd alle filtre for at se disse produkter.

Snævre resultater

Snævre resultater

Kategori

Brands

  • (10)

specielle programmer

  • (10)
Søgning efter nøgleord:
1 – 3 af 3 Resultater
1

Atrasentan hydrochloride, MedChemExpress

MedChemExpress Atrasentan hydrochloride (ABT-627 hydrochloride) is a selective endothelin A receptor antagonist with an IC50 of 0.0551 nM for ETA.

ENCOMPASS_PREFERRED
Kemisk navn eller materiale Atrasentan hydrochloride
Sundhedsfare 1 H302∣H315∣H319∣H335
Formel vægt 547.08
Opløselighedsinformation DMSO : ≥ 100 mg/mL (182.79 mM) ∣H2O : 0.5 mg/mL (0.91 mM; ultrasonic and warming and adjust pH to 4 with HCl and heat to 60°C) ∣0.1 M HCL : < 1 mg/mL (ultrasonic;warming;adjust pH to 1 with HCl;heat to 60°C) (insoluble)
Procent renhed 99.51%
Fysisk form Solid
Farve Off-White
Grad Research
Anbefalet opbevaring 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture)
Molekylvægt (g/mol) 547.08
CAS 195733-43-8
Synonym ABT-627 hydrochloride(+)-A 127722 hydrochlorideA-147627 hydrochloride
Holdbarhed 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture)
SMIL O=C([C@H]1[C@H](C2=CC=C(OC)C=C2)N(CC(N(CCCC)CCCC)=O)C[C@@H]1C3=CC=C(OCO4)C4=C3)O.Cl
Renhedsgrad noter Research
Molekylær formel C29H39ClN2O6
Til brug med (applikation) Cancer-programmed cell death
2

Linaclotide, MedChemExpress

MedChemExpress Linaclotide is a potent and selective guanylate cyclase C agonist; developed for the treatment of constipation-predominant irritable bowel syndrome (IBS-C) and chronic constipation.

ENCOMPASS_PREFERRED
Kemisk navn eller materiale Linaclotide
Formel vægt 1526.74
Opløselighedsinformation DMSO : 50 mg/mL (32.75 mM; Need ultrasonic) ∣H2O : 16.67 mg/mL (10.92 mM; ultrasonic and adjust pH to 2 with HCl)
Procent renhed 97.42%
Fysisk form Solid
Farve White
Grad Research
Anbefalet opbevaring Powder -80°C 2 years, -20°C 1 year∣In solvent -80°C 6 months, -20°C 1 month
Molekylvægt (g/mol) 1526.74
CAS 851199-59-2
Holdbarhed Powder -80°C 2 years, -20°C 1 year∣In solvent -80°C 6 months, -20°C 1 month
SMIL O=C([C@@H](NC([C@@](CSSC[C@@H]1N)([H])NC([C@@](CSSC[C@H](N2)C(N[C@H](C(O)=O)CC3=CC=C(O)C=C3)=O)([H])NC([C@@H](NC([C@@H](N4)CCC(O)=O)=O)CC5=CC=C(O)C=C5)=O)=O)=O)CC(N)=O)N6[C@@](C(N[C@H](C(N[C@](CSSC[C@](C4=O)([H])NC1=O)([H])C(NC(C(NCC2=O)=O)[C@H](O)C)=O)=O)C)=O)([H])CCC6
Renhedsgrad noter Research
Molekylær formel C59H79N15O21S6
3

Lurasidone Hydrochloride, MedChemExpress

MedChemExpress Lurasidone (Hydrochloride) (SM-13496 (Hydrochloride)) is an antagonist of both dopamine D2 and 5-HT7 with IC50s of 1.68 and 0.495 nM, respectively. Lurasidone (Hydrochloride) (SM-13496 (Hydrochloride)) is also a partial agonist of 5-HT1A receptor with an IC50 of 6.75 nM.

ENCOMPASS_PREFERRED
Kemisk navn eller materiale Lurasidone Hydrochloride
Formel vægt 529.14
Opløselighedsinformation DMSO : 6.67 mg/mL (12.61 mM; ultrasonic and warming and adjust pH to 3 with HCl and heat to 80°C) ∣Ethanol : 2 mg/mL (3.78 mM; Need ultrasonic) ∣H2O : < 0.1 mg/mL (insoluble)
Procent renhed 97.75%
Fysisk form Powder
Farve Off-White
Grad Research
Anbefalet opbevaring 4°C, sealed storage, away from moisture and light∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture and light)
Molekylvægt (g/mol) 529.14
CAS 367514-88-3
Synonym SM-13496 Hydrochloride
Holdbarhed 4°C, sealed storage, away from moisture and light∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture and light)
SMIL O=C([C@H]([C@H]1CC[C@@H]2C1)[C@H]2C3=O)N3C[C@@H]4CCCC[C@H]4CN(CC5)CCN5C6=NSC7=CC=CC=C76.Cl
Renhedsgrad noter Research
Molekylær formel C28H37ClN4O2S
Til brug med (applikation) Neuroscience-Neuromodulation